🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to look at subjects who receive Lenalidomide, D...
Status
Terminated
Location
Pacific Hematology Oncology Associates
Start Date
2013-09-30
Trial ID
NCT01891643
Treatments Being Tested
To evaluate functional, clinical, and subjective parameters in patients wit...
Status
Completed
Location
Luc Vandenbossche
Start Date
2013-04
Trial ID
NCT01702233
Treatments Being Tested
The purpose of this study is to assess the effect of Dexamethasone on posto...
Status
Completed
Location
Uniklinik Balgrist
Start Date
2021-03-11
Trial ID
NCT04610398
Treatments Being Tested
RATIONALE: Diphenhydramine, lorazepam, and dexamethasone may help lessen or...
Status
Terminated
Location
Children's Hospital of Southwest Florida
Start Date
2007-10
Trial ID
NCT00429702
Treatments Being Tested
This study will assess the control of inflammation at days 1, 7, 14, and 21...
Status
Recruiting
Location
Cole Eye Institute, Cleveland Clinic
Start Date
2020-06-01
Trial ID
NCT04371445
Treatments Being Tested
Paclitaxel 30 mg/m2 twice/week Trastuzumab 4mg/kg, loading dose, then 2 mg/...
Status
Terminated
Location
Weill Medical College of Cornell University
Start Date
2002-06
Trial ID
NCT02297230
Treatments Being Tested
This multicenter observational study will assess the efficacy and tolerabil...
Status
Completed
Location
Multiple Locations
Start Date
2011-10
Trial ID
NCT01568021
Treatments Being Tested
Primary objective of the study is the determination of the maximum tolerate...
Status
Completed
Location
University Medical Center Freiburg
Start Date
2011-08
Trial ID
NCT01394354
Treatments Being Tested
The purpose of the study is to determine whether the addition of Elotuzumab...
Status
Completed
Location
Compassionate Cancer Res Grp
Start Date
2011-11-30
Trial ID
NCT01478048
Treatments Being Tested
Acute lymphoblastic leukemia (ALL) is the most common cancer diagnosed in c...
Status
Active Not Recruiting
Location
Boston Children's Hospital
Start Date
2017-03-03
Trial ID
NCT03020030